Abbott buys Topera, enters new heart-treatment market

SHARE Abbott buys Topera, enters new heart-treatment market

Abbott Laboratories is moving into a new area for heart treatments with the purchase of medical device company Topera Inc.

The North Chicago company announced Wednesday it will pay $250 million for Menlo Park, California-based Topera, which makes catheters used in treating people with atrial fibrillation, a common heart rhythm disorder.

Continue reading at Newsfeed.

The Latest
The location becomes the seventh in the Chicago area to align with Workers United, part of the Service Employees International Union.
A four-star prospect and a pair of teammates are among the area’s top running backs.
It is not clear if the city will follow the recommendations of the Chicago monuments project advisory committee. In May, Mayor Lori Lightfoot hinted strongly at ignoring them.
After the GOP candidate for governor again ripped the city, where over one fifth of the state’s residents live, Mayor Lightfoot snapped back on Twitter.